Cargando…
Medication non-adherence and therapeutic inertia independently contribute to poor disease control for cardiometabolic diseases
Poorly controlled cardiometabolic biometric health gap measures [e.g.,uncontrolled blood pressure (BP), HbA1c, and low-density lipoprotein cholesterol (LDL-C)] are mediated by medication adherence and clinician-level therapeutic inertia (TI). The study of comparing relative contribution of these two...
Autores principales: | Yan, Xiaowei, Mudiganti, Satish, Husby, Hannah, Hudnut, Andrew, Gbotoe, Madina, Jones, J. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640683/ https://www.ncbi.nlm.nih.gov/pubmed/36344613 http://dx.doi.org/10.1038/s41598-022-21916-8 |
Ejemplares similares
-
Evaluating the Impact of a Point-of-Care Cardiometabolic Clinical Decision Support Tool on Clinical Efficiency Using Electronic Health Record Audit Log Data: Algorithm Development and Validation
por: Yan, Xiaowei, et al.
Publicado: (2022) -
Persistent Cardiometabolic Health Gaps: Can Therapeutic Care Gaps Be Precisely Identified from Electronic Health Records
por: Yan, Xiaowei, et al.
Publicado: (2021) -
Adherence, control of cardiometabolic factors and therapeutic inertia in patients with type 2 diabetes in the primary care setting
por: Orozco‐Beltrán, Domingo, et al.
Publicado: (2021) -
Nonadherence, Clinical Inertia, or Therapeutic Inertia?
por: Allen, J. Daniel, et al.
Publicado: (2009) -
Obesity management: at the forefront against disease stigma and therapeutic inertia
por: Busetto, Luca, et al.
Publicado: (2021)